Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.37
+0.07 (1.06%)
Jul 8, 2025, 2:38 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 7.16 million as of July 8, 2025. Its market cap has increased by 134.63% in one year.
Market Cap
7.16M
Enterprise Value
6.75M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.37
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.16M, a decrease of -73.75%. That is a compound annual growth rate of -16.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.28B |
| GSK plc | 56.85B |
| Haleon | 33.95B |
| Smith & Nephew | 9.73B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 1.96B |
| Oxford Nanopore Technologies | 1.42B |